RT Journal Article
SR Electronic
T1 Neurophysiological and brain structural markers of cognitive frailty differs from Alzheimer’s disease
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.06.21249338
DO 10.1101/2021.01.06.21249338
A1 Ece Kocagoncu
A1 David Nesbitt
A1 Tina Emery
A1 Laura Hughes
A1 Richard N. Henson
A1 Cam-CAN
A1 James B. Rowe
YR 2021
UL http://medrxiv.org/content/early/2021/01/06/2021.01.06.21249338.abstract
AB With increasing life span, there is growing importance of understanding the mechanisms of successful cognitive ageing. In contrast, cognitive frailty has been proposed to be a precursor to Alzheimer’s disease. Here we test the hypothesis that cognitively frail adults represent a branch of healthy ageing, distinct from latent dementia. We used electro-magnetoencephalography and magnetic resonance imaging to investigate the structural and neurophysiological features of cognitive frailty in relation to healthy aging, and clinical presentations of mild cognitive impairment and Alzheimer’s disease. Cognitive performance of the cognitively frail group was similar to those with mild cognitive impairment. We used a novel cross-modal oddball task to induce mismatch responses to unexpected stimuli. Both controls and cognitively frail showed stronger mismatch responses and larger temporal grey matter volume, compared to people with mild cognitive impairment and Alzheimer’s disease. Our results suggest that cognitively frail represents a spectrum of normal ageing rather than incipient or undiagnosed Alzheimer’s disease. Lower cognitive reserve, hearing impairment and medical comorbidity might contribute to the aetiology of cognitive impairment.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe Cam-CAN Frail study is funded by the Medical Research Council [SUAG/004 RG91365 & SUAG/046 RG101400]. JBR is supported by the Wellcome Trust [103838] and Medical Research Council [SUAG/004 RG91365]. RNH and TE are supported by the Medical Research Council [SUAG/046 RG101400]. EK is funded by the Dementias Platform UK [MR/L023784/1 & MR/L023784/2], Alzheimer's Research UK [ARUK-PG2017B-19] and the Holt Fellowship. LH is funded by the Wellcome Trust [103838].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the East of England, Cambridge Central Research Ethics Committee (10/H0308/50).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDataset will be made available through the Cam-CAN data portal in the future.ACE-RAddenbrooke’s Cognitive Examination – RevisedCam-CANCambridge Centre for Ageing and NeuroscienceDAAssociative deviantdBDecibelDNNovelty deviantEEGElectroencephalogramENTEntorhinal cortexGMVGrey matter volumeHIPHippocampusLHGLeft Heschl’s gyrusLIFGLeft inferior frontal gyrusLSTGLeft superior temporal gyrusMCIMild cognitive impairmentMEGMagnetoencephalogramMMSEMini Mental State ExaminationMNIMontreal Neurological InstituteMRIMagnetic Resonance ImagingRHGRight Heschl’s gyrusRIFGRight inferior frontal gyrusRSTGRight superior temporal gyrusRMSRoot-mean-squareROIRegion of interestSTDStandardTIVTotal intracranial volume.